Study results suggest that surgical aortic valve replacement (SAVR) and transfemoral transcatheter aortic valve replacement (TAVR) appears to have comparable short-term outcomes. The all-cause mortality rate at 1 year was 13.8% for transfemoral TAVR and 13.6% for SAVR. Rates of death from any cause and major adverse cardiac and cerebrovascular events were 18.2% for transfemoral TAVR and 17.6% for SAVR. The incidence rates for cerebrovascular events and rehospitalization due to cardiac reasons and acute heart failure were also similar for both groups at 1 year.
January 23, 2020
April 25, 2012